Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000877985 | SCV001020813 | benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000877985 | SCV001961086 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | TRIM63: BP4, BP7, BS2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001702060 | SCV004029752 | benign | not specified | 2023-07-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000877985 | SCV005264097 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001702060 | SCV001931845 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000877985 | SCV001959268 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004756062 | SCV005352430 | likely benign | TRIM63-related disorder | 2024-03-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |